Four things to know:
1. Citrate is designed for orthopedic surgery and is made with the company’s patented Citregen biomaterial.
2. The implant is reabsorbed and replaced by the patient’s bone and lets Citrepore guide healing metabolically.
3. Citrepore has more than 80% porosity and is osteoconductive and bioactive.
4. The implant is available in a variety of performed shapes and sizes and can be cut or morselized.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
